EP1054957A1 - Alkaline bacillus amylase - Google Patents

Alkaline bacillus amylase

Info

Publication number
EP1054957A1
EP1054957A1 EP99903592A EP99903592A EP1054957A1 EP 1054957 A1 EP1054957 A1 EP 1054957A1 EP 99903592 A EP99903592 A EP 99903592A EP 99903592 A EP99903592 A EP 99903592A EP 1054957 A1 EP1054957 A1 EP 1054957A1
Authority
EP
European Patent Office
Prior art keywords
amylase
alpha
dna sequence
activity
bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99903592A
Other languages
German (de)
French (fr)
Inventor
Helle Outtrup
Bjarne Roenfeldt Nielsen
Lisbeth Hedegaard
Jens Toenne Andersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of EP1054957A1 publication Critical patent/EP1054957A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411Amylases
    • C12N9/2414Alpha-amylase (3.2.1.1.)
    • C12N9/2417Alpha-amylase (3.2.1.1.) from microbiological source
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase

Definitions

  • the present invention relates to amylases having improved washing performance m an alkaline detergent solution at low temperature .
  • a-amylase enzymes have been used for a variety of different purposes, the most important of which are starch liquefaction, textile desizing, starch modification m the paper and pulp industry, and for brewing and baking.
  • a further use of a-amylases, which is becoming increasingly important is the removal of starchy stains during washing with a detergent at alkaline pH.
  • a-amylase products examples include Termamyl ® , BAN ® and Fungamyl ® , all available from Novo Nordisk A/S, Denmark. These and similar products from other commercial sources have an acidic to a neutral pH optimum, typically m the range of from pH 5 to pH 7.5, and they do not display optimal activity m detergent solutions at alkaline pH.
  • WO 95/26397 discloses an a-amylase from a Bacillus strain which has optimum activity at pH 8.
  • WO 96/23873 describes variants of Bacillus amylases with improved performance under washing conditions.
  • alpha-amylase which is: a) a polypeptide produced by Bacillus sp . NCIMB 40916, or b) a polypeptide having an ammo acid sequence as shown m positions 32-532 of SEQ ID NO: 2, or c) a polypeptide encoded by the alpha-amylase encoding part of the DNA sequence cloned into a plasmid present m Escheri chi a col l DSM 12662, or d) an analogue of the polypeptide defined m (a) or (b) which :
  • the invention provides an a-amylase having one or more of the following characteristics:
  • thermostability such that it retains more than 90 % of its activity after 20 minutes incubation at 25°C m a solution of 3 g/1 of a test detergent containing 20% STPP, 25% Na2S04,
  • the invention also provides an isolated DNA sequence which encodes an alpha-amylase, wherem the alpha-amylase is that described above, or where the DNA sequence comprises: a) the DNA sequence shown m positions 94-1596 of SEQ ID NO : 1 , or b) an analogue of the DNA sequence defined m a) which l) is at least 60 % homologous with said DNA sequence, or n) hybridizes with said DNA sequence at least 55°C.
  • Other aspects of the invention provide a recombmant expression vector comprising the DNA sequence, and a cell transformed with the DNA sequence or the recombmant expression vector.
  • the invention also provides a method for producing an alpha-amylase by cultivating the cell and a detergent composition comprising said alpha-amylase.
  • Fig. 1 shows a pH activity profile of the amylase from NCIMB 40916 compared to two prior-art amylases (SP722 and Termamyl) .
  • Fig. 2 shows a temperature activity profile of the amylase from NCIMB 40916.
  • Fig. 3 shows the stability of the amylase from NCIMB 40916 after incubation at various temperatures.
  • Fig. 4 shows the cloning vector pSJ1678 described Example 1.
  • Figs. 5 and 6 show results of washing tests described in Example 4.
  • the alpha-amylase of the invention may be derived from a strain of Bacillus .
  • a preferred strain is Bacillus sp . NCIMB 40916. This strain was deposited on 28 January 1998 by the inventors under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure at the National Collections of Industrial and Marine Bacteria Limited (NCIMB), 23 St. Machar Drive, Aberdeen AB2 1RY, Scotland, United Kingdom.
  • a Escheri - chia coli strain termed JA388 containing the alpha amylase gene cloned m plasmid pJA388 has also been deposited on 3 February 1999 under the terms of the Budapest Treaty with the Deutshe Sammmlung von Microorganismen und Zellkulturen GmbH (DSMZ) , Mascheroder Weg lb, D-38124 Braunschweig DE, and given the accession number DSM 12662.
  • DSMZ Deutshe Sammmlung von Microorganismen und Zellkulturen GmbH
  • the alpha-amylase of the invention can be produced by cultivating a suitable amylase-producmg strain of Bacillus or the transformed host cell of the invention m a suitable nutrient medium, and recovering the alpha-amylase from the cul - ture medium.
  • the medium used to cultivate the cells may be any conventional medium suitable for growing the host cell m question and obtaining expression of the a-amylase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published recipes (e.g. as described m catalogues of the American Type Culture Collection) .
  • the a-amylase secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating protemaceous components of the medium by means of a salt such as ammonium sulphate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • a preferred alpha-amylase is derived from Bacillus sp . NCIMB 40916. It can be produced as described m the examples. The ammo acid sequence of the amylase and of the DNA encoding it are shown m SEQ ID NO: 1 and 2. The following characteristics were found for an amylase of the mvention (purified alpha-amylase from NCIMB 40916) :
  • a pH-activity curve is shown m Fig. 1, taking the activity at pH 7.3 as 100%. It was determined using the Phadebas assay usmg 50 mM Britten-Robmson buffer ad usted to various pH-values.
  • the pH profiles of two prior- art Bacillus amylases (Termamyl derived from B . licheniformis and SP722 produced according to WO 95/26397) were measured under the same conditions are also shown m Figure 1.
  • Figure 1 shows that the amylase of the invention has about 10 times higher activity than the two prior-art amylases at pH 9.5.
  • Fig. 1 also shows that the optimum activity is about pH 9.5.
  • a temperature-activity curve was measured usmg the Phadebas assay at various temperatures with 50 mM Britten- Robmson buffer adjusted to pH 9.5. The results are shown m Fig. 2. It is seen from Fig. 2 that the amylase of the invention has optimum activity at about 55°C.
  • Stability of the amylase was measured at pH 10.5 (50 mM CAPS) at 22, 37, 45, 55 and 65 °C after 30 minutes incubation.
  • the enzyme was diluted to 40 NU/ml m buffer and 25 microlitre sample was incubated at the respective temperatures. After 30 minutes, the samples was chilled on ice and residual activity was determined.
  • a stability profile of the amylase of the mvention and a prior-art amylase (SP722) is shown m Figure 3.
  • the ammo acid sequence homology may be determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second.
  • the homology may suitably be determined by means of computer programs known m the art.
  • FASTA provided m GCG version 8 (Needleman, S.B. and Wunsch, CD., (1970), Journal of Molecular Biology, 48, 443-453) may be used with the following settings: Scoring matrix: GenRunData :blosum50. cmp, Variable pa factor used Gap creation penalty: 12, Gap extension penalty: 2.
  • m GCG version 8 Needleman, S.B. and Wunsch, CD., (1970), Journal of Molecular Biology, 48, 443-453
  • Scoring matrix GenRunData :blosum50. cmp
  • Variable pa factor used Gap creation penalty: 12
  • Gap extension penalty 2.
  • Gap from GCG version 9 may be used with a translated version 8 peptide scoring matrix, a gap creation penalty of 30, a gap extension penalty of 1 using ntol ' s matrix
  • the ammo acid sequence exhibits a degree of identity preferably of at least 60%, preferably at least 70%, more preferably at least 80%, especially at least 90% or at least 95%, with the ammo acid sequence shown m positions 32-532 of SEQ ID NO: 2.
  • the DNA sequence homology may be determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second.
  • the homology may suitably be determined by means of computer programs known m the art such as GAP provided m the GCG program package (described above) .
  • GAP uses the method of Needleman/Wunsch/Sellers to make alignments.
  • the DNA construct of the present invention comprises a DNA sequence exhibiting a degree of identity preferably of at least 60%, preferably at least 70%, more preferably at least 80%, especially at least 90% or at least 95%, with the nucleic acid sequence shown m positions 94-1596 of SEQ ID NO: 1.
  • the hybridization is used to indicate that a given DNA sequence is analogous to a nucleotide probe corresponding to SEQ ID NO : 1.
  • the hybridization conditions are described m detail below.
  • Suitable conditions for determining hybridization between a nucleotide probe and a homologous DNA or RNA sequence involves presoakmg of the filter containing the DNA fragments or RNA to hybridize m 5 x SSC (standard saline citrate) for 10 mm, and prehybridization of the filter m a solution of 5 x SSC (Sambrook et al . 1989), 5 x Denhardt ' s solution (Sambrook et al . 1989), 0.5 % SDS and 100 ⁇ g/ml of denatured sonicated salmon sperm DNA (Sambrook et al . 1989), followed by hybridization m the same solution containing a random-primed (Femberg, A. P.
  • Molecules to which the oligonucleotide probe hybridizes under these conditions are detected using a x-ray film.
  • the expression vector of the invention typically includes control sequences encoding a promoter, operator, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes.
  • the recombinant expression vector carrying the DNA sequence encoding the a-amylase of the invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced.
  • the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid, a bacteriophage or an extrachromosomal element, m ichromosome or an artificial chromosome.
  • the vector may be one which, when introduced mto a host cell, is integrated mto the host cell genome and replicated together with the chromosome (s) into which it has been integrated.
  • the DNA sequence should be operably connected to a suitable promoter sequence.
  • the promoter may be any DNA sequence which shows transcriptional activity m the host cell of choice and may be derived from genes encoding pro- terns either homologous or heterologous to the host cell .
  • suitable promoters for directing the transcription of the DNA sequence encoding an a-amylase of the invention, especially a bacterial host are the promoter of the lac operon of E .
  • coli the Streptomyces coeli color agarase gene dagA promoters, the promoters of the Bacillus licheniformi s a- amylase gene ⁇ amyL) , the promoters of the Bacillus stearothermophilus maltogenic amylase gene ⁇ amyM) , the promoters of the Bacillus Amyloliquefaciens a-a ylase ( amyQ) , the promoters of the Bacillus subtili s xylA and xylB genes etc.
  • useful promoters are those derived from the gene encoding A .
  • oryzae TAKA amylase Rhizomucor wiehei aspartic protemase, A . niger neutral a-amylase, A . niger acid stable a-amylase, A . niger glu- coamylase, Rhizomucor miehei lipase, A . oryzae alkaline protease, A . oryzae triose phosphate isomerase or A . nidulans acetamidase .
  • the expression vector of the invention may also comprise a suitable transcription terminator and, m eukaryotes, poly- adenylation sequences operably connected to the DNA sequence encoding the a-amylase of the invention. Termination and poly- adenylation sequences may suitably be derived from the same sources as the promoter.
  • the vector may further comprise a DNA sequence enabling the vector to replicate m the host cell m question.
  • a DNA sequence enabling the vector to replicate m the host cell m question.
  • sequences are the origins of replication of plasmids pUC19, pACYC177, pUBHO, pE194, pAMBl and pIJ702.
  • the vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect m the host cell, such as the dal genes from B . subtili s or B . li chemfor- mis , or one which confers antibiotic resistance such as ampi- cillm, kanamycm, chloramphenicol or tetracyclm resistance.
  • a selectable marker e.g. a gene the product of which complements a defect m the host cell, such as the dal genes from B . subtili s or B . li chemfor- mis , or one which confers antibiotic resistance such as ampi- cillm, kanamycm, chloramphenicol or tetracyclm resistance.
  • the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and sC, a marker giving rise to hygromyc resistance, or the selection may be accomplished by co-
  • the cell of the invention is advantageously used as a host cell m the recombinant production of the a-amylase of the invention.
  • the cell may be transformed with the DNA construct of the invention encoding the amylase, conveniently by integrating the DNA construct (m one or more copies) m the host chromosome. This integration is generally considered to be an advantage as the DNA sequence is more likely to be stably maintained the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g. by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above m connection with the different types of host cells.
  • the cell of the invention may be a cell of a higher organism such as a mammal or an insect, but is preferably a microbial cell, e.g. a bacterial or a fungal (including yeast) cell. 10
  • Examples of bacterial host cells which, on cultivation, are capable of producing the enzyme of the invention are gram-positive bacteria such as strains of Bacillus, such as strains of B . subtilis , B . li chenifor i s , B . lentus, B . clausn , B . brevi s, B . s tearothermophilus, B . alkalophilus , B . amyloliquefaciens, B . coagulans , B . circulans , B . lautus , B . mega terium or B . thuringi ensi s, or strains of Streptomyces, such as S . lividans or S .
  • Bacillus such as strains of B . subtilis , B . li chenifor i s , B . lentus, B . clausn , B . brevi s, B . s tearother
  • the transformation of the bacteria may be effected by protoplast transformation, electroporation, conjugation, or by using competent cells m a manner known per se (cf. Sambrook et al . , supra) .
  • the yeast organism may favourably be selected from a species of Saccharomyces or Schizosaccharomyces , e.g. Saccharomyces cerevi siae .
  • the filamentous fungus may advantageously belong to a species of Aspergillus, e.g. Aspergillus oryzae or Aspergillus niger.
  • Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall m a manner known per se . A suitable procedure for transformation of Aspergillus host cells is described m EP 238 023.
  • the a- amylases of the invention are well suited for use m a variety of industrial processes, m particular the enzyme finds potential applications as a component m detergents, e.g. laundry and hard surface cleaning detergent compositions, but it may also be useful the production of sweeteners and ethanol from starch.
  • m detergents e.g. laundry and hard surface cleaning detergent compositions
  • sweeteners and ethanol from starch.
  • it may be used m conventional starch- converting processes, such as liquefaction and saccharification processes described US Patent No. 3,912,590 and EP patent publications Nos . 252,730 and 63,909.
  • the alkaline a-amylase of the invention may also be used in the production of lignocellulosic materials, such as pulp, paper and cardboard, from starch reinforced waste paper and cardboard, especially where repulp g occurs at pH above 7 and 11
  • amylases can facilitate the disintegration of the waste material through degradation of the reinforcing starch.
  • the a- amylase of the mvention is especially useful m a process for producing a paper akmg pulp from starch-coated printed paper. The process may be performed as described m WO 95/14807, comprising the following steps: a) disintegrating the paper to produce a pulp, b) treating with a starch-degrading enzyme before, during or after step a) , and c) separating ink particles from the pulp after steps a) and b) .
  • the a-amylases of the invention may also be very useful m modifying starch where enzymatically modified starch is used papermakmg together with alkaline fillers such as calcium carbonate, kaolin and clays. With the alkaline a-amylases of the invention it becomes possible to modify the starch the presence of the filler thus allowing for a simpler integrated process .
  • the a-amylase of the invention may also be very useful m textile desizmg.
  • a- amylases are traditionally used as auxiliaries m the desizmg process to facilitate the removal of starch-contammg size which has served as a protective coatmg on weft yarns during weaving. Complete removal of the size coatmg after weaving is important to ensure optimum results m the subsequent processes, m which the fabric is scoured, bleached and dyed. Enzymatic starch break-down is preferred because it does not involve any harmful effect on the fiber material . In order to reduce processing cost and increase mill throughput, the desizmg processing is sometimes combined with the scouring and bleaching steps.
  • non-enzymatic auxiliaries such as alkali or oxidation agents are typically used to break down the starch, because traditional a-amylases are not very compatible with high pH levels and bleaching agents.
  • the non- enzymatic breakdown of the starch size does lead to some fiber damage because of the rather aggressive chemicals used. Accordingly, it would be desirable to use the a-amylases of the 12
  • the a-amylases may be used alone or m combination with a cellulase when desizmg cellulose-containing fabric or textile .
  • the a-amylases of the invention may also be very useful m a beer-making process; the a-amylases will typically be added during the mashing process.
  • the a-amylase may typically be a component of a detergent composition, e.g., a laundry detergent composition.
  • a detergent composition e.g., a laundry detergent composition.
  • the detergent composition may be included m the detergent composition m the form of a non-dustmg granulate, a stabilized liquid, or a protected enzyme.
  • Non-dustmg granulates may be produced, e.g., as disclosed m US 4,106,991 and 4,661,452 (both to Novo Industri A/S) and may optionally be coated by methods known m the art.
  • waxy coatmg materials are poly (ethylene oxide) products (polyethyleneglycol , PEG) with mean molecular weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols m which the alcohol contains from 12 to 20 carbon atoms and m which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and t ⁇ glycerides of fatty acids.
  • PEG poly (ethylene oxide) products
  • PEG polyethyleneglycol
  • Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol , a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
  • a polyol such as propylene glycol
  • sugar or sugar alcohol a sugar or sugar alcohol
  • lactic acid or boric acid a polyol
  • Other enzyme stabilizers are well known m the art.
  • Protected enzymes may be prepared according to the method disclosed m EP 238,216.
  • the properties of the alpha-amylase of the invention make it particularly suitable for use m alkaline detergents, e.g. at pH 9.5-10.5, and for washing at low temperatures, e.g. 20- 40°C.
  • the detergent composition of the invention may be any convenient form, e.g. as powder, granules, paste or liquid.
  • liquid detergent may be aqueous, typically containing up to 70% water and 0-30% organic solvent, or non-aqueous.
  • the detergent composition comprises one or more surfactants, each of which may be anionic, nonionic, cationic, or amphoteric (zwitterionic) .
  • the detergent will usually contain 0-50% of anionic surfactant such as linear alkylbenzene- sulfonate (LAS) , alpha-olefmsulfonate (AOS) , alkyl sulfate (fatty alcohol sulfate) (AS), alcohol ethoxysulfate (AEOS or AES) , secondary alkanesulfonates (SAS) , alpha-sulfo fatty acid methyl esters, alkyl- or alkenylsuccmic acid, or soap.
  • anionic surfactant such as linear alkylbenzene- sulfonate (LAS) , alpha-olefmsulfonate (AOS) , alkyl sulfate (fatty alcohol sulfate) (AS), alcohol ethoxysul
  • nonionic surfactant such as alcohol ethoxylate (AEO or AE) , alcohol propoxylate, carboxylated alcohol ethoxylates, nonylphenol ethoxylate, alkylpolygly- coside, alkyldimethylamme oxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, or polyhydroxy alkyl fatty acid amide (e.g. as described m WO 92/06154) .
  • AEO or AE alcohol ethoxylate
  • alcohol propoxylate carboxylated alcohol ethoxylates
  • nonylphenol ethoxylate nonylphenol ethoxylate
  • alkylpolygly- coside alkyldimethylamme oxide
  • ethoxylated fatty acid monoethanolamide e.g. as described m WO 92/06154
  • polyhydroxy alkyl fatty acid amide e.g. as described m WO 92/06154
  • the detergent composition may additionally comprise one or more other enzymes, such as pullulanase, esterase, lipase, cutmase, protease, cellulase, peroxidase, or oxidase, e.g., laccase.
  • enzymes such as pullulanase, esterase, lipase, cutmase, protease, cellulase, peroxidase, or oxidase, e.g., laccase.
  • the detergent contains 1-65% of a detergent builder or complexmg agent such as zeolite, diphosphate, tri- phosphate, phosphonate, citrate, mtrilotriacetic acid (NTA) , ethylenediammetetraacetic acid (EDTA) , diethylenet ⁇ - ammepentaacetic acid (DTMPA) , alkyl- or alkenylsuccmic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst) .
  • a detergent builder or complexmg agent such as zeolite, diphosphate, tri- phosphate, phosphonate, citrate, mtrilotriacetic acid (NTA) , ethylenediammetetraacetic acid (EDTA) , diethylenet ⁇ - ammepentaacetic acid (DTMPA) , alkyl- or alkenylsuccmic acid, soluble silicates or layered silicates (e.g.
  • the detergent builders may be subdivided into phosphorus- containing and non-phosphorous-containing types.
  • phosphorus-containing inorganic alkaline detergent builders include the water-soluble salts, especially alkali metal pyrophosphates, orthophosphates , polyphosphates and phospho- nates .
  • non-phosphorus-containing inorganic builders include water-soluble alkali metal carbonates, borates and silicates as well as layered disilicates and the various types of water-insoluble crystalline or amorphous alummo silicates of which zeolites is the best known representative. 14
  • suitable organic builders include alkali metal, ammonium or substituted ammonium salts of succmates, malonates, fatty acid malonates, fatty acid sulphonates, carboxymethoxy succmates, polyacetates , carboxylates , polycar- boxylates, ammopolycarboxylates and polyacetyl carboxylates.
  • the detergent may also be unbuilt, i.e. essentially free of detergent builder.
  • the detergent may comprise one or more polymers.
  • examples are carboxymethylcellulose (CMC), poly (vmylpyrrolidone) (PVP) , polyethyleneglycol (PEG), poly (vinyl alcohol) (PVA) , poly- carboxylates such as polyacrylates, polymaleates , maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • CMC carboxymethylcellulose
  • PVP poly (vmylpyrrolidone)
  • PEG polyethyleneglycol
  • PVA poly (vinyl alcohol)
  • poly- carboxylates such as polyacrylates, polymaleates , maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent composition may contain bleaching agents of the chlorme/bromme-type or the oxygen-type.
  • the bleaching agents may be coated or encapsulated.
  • Examples of inorganic chlorme/bromme-type bleaches are lithium, sodium or calcium hypochlo ⁇ te or hypobromite as well as chlorinated t ⁇ sodium phosphate.
  • Examples of organic chlorme/bromme-type bleaches are heterocyclic N-bromo and N- chloro lmides such as trichloroisocyanu ⁇ c , t ⁇ bromoiso- cyanuric, dibromoisocyanuric and dichloroisocyanuric acids, and salts thereof with water solubiliz g cations such as potassium and sodium. Hydantom compounds are also suitable.
  • the bleaching system may also comprise peroxyacids of, e.g., the amide, lmide, or sulfone type.
  • the oxygen-type bleach may be an inorganic persalt, preferably with a bleach activator, or a peroxy acid compound.
  • inorganic persalts are alkali metal perborates, both tetrahydrates and monohydrates, alkali metal percarbonates , persilicates and perphosphates .
  • the activator may be tetraacetylethylenediamme (TAED) or nonanoyloxybenzene- sulfonate (NOBS) .
  • the enzymes of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g. a polyol such as propylene glycol or glycerol , a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative 15
  • the composition may be formulated as described in, e.g., WO 92/19709 and WO 92/19708.
  • the enzymes of the invention may also be stabilized by adding reversible enzyme inhibitors, e.g., of the protein type as described in EP 0 544 777 Bl .
  • the detergent may also contain other conventional detergent ingredients such as, e.g., fabric conditioners including clays, deflocculant material, foam boosters, foam depressors, suds suppressors, anti -corrosion agents, soil -suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides , optical brighteners, or perfume.
  • fabric conditioners including clays, deflocculant material, foam boosters, foam depressors, suds suppressors, anti -corrosion agents, soil -suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides , optical brighteners, or perfume.
  • the pH (measured in aqueous solution at use concentration) will usually be neutral or alkaline, e.g. in the range of 7-11. More specifically, the alpha-amylase of the invention may be incorporated in any of the detergent formulations described in WO 96/23873.
  • the a-amylases of the invention may be incorporated in concentrations conventionally employed in detergents. It is at present contemplated that, in the detergent composition of the invention, the a-amylase may be added in an amount corresponding to 0.00001-1 mg (calculated as pure enzyme protein) of a- amylase per liter of wash liquor.
  • Escherichia coli SJ2 is described in Diderichsen, B., Wedsted, U. , Hedegaard, L., Jensen, B.R., Sj ⁇ holm, C. (1990) Journal of Bacteriology, Vol.172, No. 8, p. 4315-4321.
  • the gene bank vector was pSJ1678 which is further disclosed in W094/19454 which is hereby incorporated by reference. 16
  • the gene bank vector pSJ1678 is further disclosed m WO 94/19454 which is hereby incorporated by reference.
  • A/P (Asia/Pacific) Model Detergent has the following composition: 20% STPP (sodium tripolyphosphate) , 25% Na 2 S0 4 ,
  • DNA was isolated from Bacillus sp . NCIMB 40916 by the method of Pitcher, D. G., Saunders,N. A., and Owen, R. J.
  • This gene library was screened for alpha amylase activity and the strain showing alpha amylase activity was termed JA388.
  • This Escheri chia coli strain JA388 which was deposited and given the accession number DSM 12662, and which harbours the plasmid termed pJA388 encoding the alpha amylase was used for DNA sequencing.
  • the Alpha amylase gene cloned in plasmid pJA388 was characterized by DNA sequencing by primer walking, using the
  • Taq deoxytermmal cycle sequencing kit (Perkm Elmer, USA) , fluorescent labeled terminators and appropriate oligonucleotides as primers.
  • the signal peptide and the mature alpha amylase are presented m SEQ ID NO: 2.
  • the deduced N-termmal sequence was verified by sequencing 34 ammo acids at the N-termmal of the protein.
  • E . coli JA388 harboring plasmid pJA388 was cultivated over night m LB-broth containing chloramphenicol 10 ⁇ g/ml , 37 °C, 250 rpm. Cells were harvested from 2.7 1 culture broth by centrifugation at 6000 rpm for 15 minutes. The mtracellular located amylase was released from the cells by using the following osmotic shock procedure:
  • the enzyme solution was applied on a Pharmacia Q Sepharose column FF previously equilibrated m EKV-buffer, pH 7, and the column was washed with EKV-buffer. Bound proteins were eluted with a linear NaCl gradient from 0-500 mM over 10 column volumes. Amylase containing fractions were pooled and dialyzed aga st EKV-buffer over night. The solution was then applied on a Q Sepharose column FF previously equilibrated m EKV-buffer, pH 8, the column was washed with EKV-buffer, and the amylase was eluted with a linear NaCl gradient from 0-500 mM over 10 column volumes. Amylase containing fractions were pooled. A Phenyl Superose column previously equilibrated m EKV- buffer, pH 8 containing 1 M ammonium sulfate was loaded with 18
  • the enzyme solution added ammonium sulfate to a concentration of 1 M. Unbound material was washed out with the ammonium sulfate buffer and the column was eluted with a linear NaCl gradient from 1-0 M ammonium sulfate over 20 column volumes. Amylase containing fractions were pooled.
  • the purified amylase was analyzed by SDS-PAGE and only one band was obtained after staining with Coomasie Blue.
  • Example 4 Washing test Washing performance was evaluated by washing soiled test swatches for 15 minutes at 25°C m a detergent solution with the alpha-amylase of the invention.
  • the detergent used was the A/P Model Detergent described above at 3 g/1 having pH 10.5, or a commercial detergent from Malaysia (FAB Total from Colgate) at 3 g/1 having a pH of approx. 9.7.
  • the purified amylase of Example 3 was added to the detergent solution at the concentration indicated below.
  • the test swatches were soiled with orange rice starch (CS-28 swatches available from CFT, Center for Test Material, Holland) .
  • ⁇ R remission of the swatch washed with the alpha-amylase minus the remission of a swatch washed at the same conditions without the alpha-amylase.
  • Alpha-amylase ⁇ R ⁇ R concentration Model detergent Malaysian detergent (mg enzyme protein

Abstract

The present invention relates to amylases having improved washing performance in an alkaline detergent solution at low temperature. More specifically, the present invention provides novel a-amylases from Bacillus sp. with improved performance in alkaline solutions, especially in alkaline detergent solutions at pH around 9-11.

Description

ALKALINE BACILLUS AMYLASE
FIELD OF INVENTION
The present invention relates to amylases having improved washing performance m an alkaline detergent solution at low temperature .
BACKGROUND OF THE INVENTION
For a number of years a-amylase enzymes have been used for a variety of different purposes, the most important of which are starch liquefaction, textile desizing, starch modification m the paper and pulp industry, and for brewing and baking. A further use of a-amylases, which is becoming increasingly important is the removal of starchy stains during washing with a detergent at alkaline pH.
Examples of commercial a-amylase products are Termamyl®, BAN® and Fungamyl®, all available from Novo Nordisk A/S, Denmark. These and similar products from other commercial sources have an acidic to a neutral pH optimum, typically m the range of from pH 5 to pH 7.5, and they do not display optimal activity m detergent solutions at alkaline pH. WO 95/26397 discloses an a-amylase from a Bacillus strain which has optimum activity at pH 8. WO 96/23873 describes variants of Bacillus amylases with improved performance under washing conditions.
US 5,147,796 describes an alkaline pullulanase having alpha-amylase activity. Fig. 2b of the document shows optimum amylase activity at pH 8-8.5.
M. Takagi et al . , J. Ferment. Bioeng., vol 81, No. 6, 557- 559 (1996) describe an alkaliphilic alpha-amylase-pullulanase from Bacillus sp . The enzyme has optimum amylase activity at pH 9, but the activity drops rapidly at higher pH, and the activity at pH 10 is lower than at pH 7.
It is an object of the present invention to provide novel a-amylases with improved performance m alkaline solutions, especially m alkaline detergent solutions at pH around 9-11. SUMMARY OF THE INVENTION
The present invention provides alpha-amylase which is: a) a polypeptide produced by Bacillus sp . NCIMB 40916, or b) a polypeptide having an ammo acid sequence as shown m positions 32-532 of SEQ ID NO: 2, or c) a polypeptide encoded by the alpha-amylase encoding part of the DNA sequence cloned into a plasmid present m Escheri chi a col l DSM 12662, or d) an analogue of the polypeptide defined m (a) or (b) which :
I) is at least 60 % homologous with said polypeptide, or li ) is derived from said polypeptide by substitution, deletion and/or insertion of one or several ammo acids. In another aspect, the invention provides an a-amylase having one or more of the following characteristics:
•an activity at pH 10.5 which is at least two times higher than the activity at pH 7.3 when measured at 37°C.
•an activity at pH 9.5 which is at least 4 times higher than the activity at pH 7.3 when measured at 37°C.
•an optimum pH of about 9.5 when measured at 37°C.
•a thermostability such that it retains more than 90 % of its activity after 20 minutes incubation at 25°C m a solution of 3 g/1 of a test detergent containing 20% STPP, 25% Na2S04,
15% Na2C03, 20% LAS, 5% C12-C15 alcohol ethoxylate, 5%
Na2Sι205, 0.3% NaCl at pH 10.5 and 6 degrees German hardness, and retains less than 90 % of its activity after 20 minutes incubation at 30°C the same solution.
•a molecular weight of about 55 kDa as determined by SDS- PAGE.
•an iso-electric point of about 5 as determined by isoelectric focusing. The invention also provides an isolated DNA sequence which encodes an alpha-amylase, wherem the alpha-amylase is that described above, or where the DNA sequence comprises: a) the DNA sequence shown m positions 94-1596 of SEQ ID NO : 1 , or b) an analogue of the DNA sequence defined m a) which l) is at least 60 % homologous with said DNA sequence, or n) hybridizes with said DNA sequence at least 55°C. Other aspects of the invention provide a recombmant expression vector comprising the DNA sequence, and a cell transformed with the DNA sequence or the recombmant expression vector.
The invention also provides a method for producing an alpha-amylase by cultivating the cell and a detergent composition comprising said alpha-amylase.
BRIEF DESCRIPTION OF DRAWINGS The present invention is further illustrated with reference to the accompanying drawings, m which:
Fig. 1 shows a pH activity profile of the amylase from NCIMB 40916 compared to two prior-art amylases (SP722 and Termamyl) . Fig. 2 shows a temperature activity profile of the amylase from NCIMB 40916.
Fig. 3 shows the stability of the amylase from NCIMB 40916 after incubation at various temperatures.
Fig. 4 shows the cloning vector pSJ1678 described Example 1.
Figs. 5 and 6 show results of washing tests described in Example 4.
DETAILED DESCRIPTION OF THE INVENTION
Microbial source The alpha-amylase of the invention may be derived from a strain of Bacillus . A preferred strain is Bacillus sp . NCIMB 40916. This strain was deposited on 28 January 1998 by the inventors under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure at the National Collections of Industrial and Marine Bacteria Limited (NCIMB), 23 St. Machar Drive, Aberdeen AB2 1RY, Scotland, United Kingdom. A Escheri - chia coli strain termed JA388 containing the alpha amylase gene cloned m plasmid pJA388 has also been deposited on 3 February 1999 under the terms of the Budapest Treaty with the Deutshe Sammmlung von Microorganismen und Zellkulturen GmbH (DSMZ) , Mascheroder Weg lb, D-38124 Braunschweig DE, and given the accession number DSM 12662.
Production of alpha-amylase
The alpha-amylase of the invention can be produced by cultivating a suitable amylase-producmg strain of Bacillus or the transformed host cell of the invention m a suitable nutrient medium, and recovering the alpha-amylase from the cul - ture medium.
The medium used to cultivate the cells may be any conventional medium suitable for growing the host cell m question and obtaining expression of the a-amylase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published recipes (e.g. as described m catalogues of the American Type Culture Collection) .
The a-amylase secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating protemaceous components of the medium by means of a salt such as ammonium sulphate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
Properties of alpha-amylase
A preferred alpha-amylase is derived from Bacillus sp . NCIMB 40916. It can be produced as described m the examples. The ammo acid sequence of the amylase and of the DNA encoding it are shown m SEQ ID NO: 1 and 2. The following characteristics were found for an amylase of the mvention (purified alpha-amylase from NCIMB 40916) :
A molecular weight of approximately 55 kDa as determined by SDS-PAGE using a Novex, 4-25% gradient gel. A pi of approximately 5 was determined by isoelectric focusing (Ampholme PAG, pH 3.5-9.5).
A pH-activity curve is shown m Fig. 1, taking the activity at pH 7.3 as 100%. It was determined using the Phadebas assay usmg 50 mM Britten-Robmson buffer ad usted to various pH-values. For reference, the pH profiles of two prior- art Bacillus amylases (Termamyl derived from B . licheniformis and SP722 produced according to WO 95/26397) were measured under the same conditions are also shown m Figure 1. Figure 1 shows that the amylase of the invention has about 10 times higher activity than the two prior-art amylases at pH 9.5. Fig. 1 also shows that the optimum activity is about pH 9.5.
A temperature-activity curve was measured usmg the Phadebas assay at various temperatures with 50 mM Britten- Robmson buffer adjusted to pH 9.5. The results are shown m Fig. 2. It is seen from Fig. 2 that the amylase of the invention has optimum activity at about 55°C.
Stability of the amylase was measured at pH 10.5 (50 mM CAPS) at 22, 37, 45, 55 and 65 °C after 30 minutes incubation. The enzyme was diluted to 40 NU/ml m buffer and 25 microlitre sample was incubated at the respective temperatures. After 30 minutes, the samples was chilled on ice and residual activity was determined. A stability profile of the amylase of the mvention and a prior-art amylase (SP722) is shown m Figure 3.
Stability was tested by incubating 40 NU/ml of amylase m a solution of 3 g/1 of the A/P model detergent described above, at pH 10.5 and 6°dH (German hardness, Ca:Mg 2:1). After the incubation, the residual activity was measured by Phadebas at pH 7.3. The results were 95 % residual activity after incubation at 25°C, and 87 % at 30°C. Homology of polypeptide and DNA sequence
The ammo acid sequence homology may be determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second. The homology may suitably be determined by means of computer programs known m the art. Thus, FASTA provided m GCG version 8 (Needleman, S.B. and Wunsch, CD., (1970), Journal of Molecular Biology, 48, 443-453) may be used with the following settings: Scoring matrix: GenRunData :blosum50. cmp, Variable pa factor used Gap creation penalty: 12, Gap extension penalty: 2. Alternatively,
Gap from GCG version 9 may be used with a translated version 8 peptide scoring matrix, a gap creation penalty of 30, a gap extension penalty of 1 using ntol ' s matrix
(http : //plasmιd/~bιoweb/matrιx/ ) without end gap penalty. The ammo acid sequence exhibits a degree of identity preferably of at least 60%, preferably at least 70%, more preferably at least 80%, especially at least 90% or at least 95%, with the ammo acid sequence shown m positions 32-532 of SEQ ID NO: 2. The DNA sequence homology may be determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second. The homology may suitably be determined by means of computer programs known m the art such as GAP provided m the GCG program package (described above) . Thus, Gap GCGvδ may be used with the following default parameters: GAP creation penalty of 5.0 and GAP extension penalty of 0.3, default scoring matrix . GAP uses the method of Needleman/Wunsch/Sellers to make alignments.
The DNA construct of the present invention comprises a DNA sequence exhibiting a degree of identity preferably of at least 60%, preferably at least 70%, more preferably at least 80%, especially at least 90% or at least 95%, with the nucleic acid sequence shown m positions 94-1596 of SEQ ID NO: 1.
A homology search of known sequences showed homologies for the sequences of the invention with a number of Bacillus amylases m the range 31-34 % on ammo acid basis and 46-48 % on DNA basis, determined as described above. Hybridization
The hybridization is used to indicate that a given DNA sequence is analogous to a nucleotide probe corresponding to SEQ ID NO : 1. The hybridization conditions are described m detail below.
Suitable conditions for determining hybridization between a nucleotide probe and a homologous DNA or RNA sequence involves presoakmg of the filter containing the DNA fragments or RNA to hybridize m 5 x SSC (standard saline citrate) for 10 mm, and prehybridization of the filter m a solution of 5 x SSC (Sambrook et al . 1989), 5 x Denhardt ' s solution (Sambrook et al . 1989), 0.5 % SDS and 100 μg/ml of denatured sonicated salmon sperm DNA (Sambrook et al . 1989), followed by hybridization m the same solution containing a random-primed (Femberg, A. P. and Vogelstem, B. (1983) Anal . Biochem . 132:6-13), 32P-dCTP-labeled (specific activity > 1 x 10° cpm/μg ) probe for 12 hours at approx. 45°C. The filter is then washed two times for 30 minutes m 2 x SSC, 0.5 % SDS at a temperature of at least 55°C, more preferably at least 60°C, more preferably at least 65°C, even more preferably at least 70°C, especially at least 75°C.
Molecules to which the oligonucleotide probe hybridizes under these conditions are detected using a x-ray film.
Recombinant expression vector The expression vector of the invention typically includes control sequences encoding a promoter, operator, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes.
The recombinant expression vector carrying the DNA sequence encoding the a-amylase of the invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid, a bacteriophage or an extrachromosomal element, m ichromosome or an artificial chromosome. Alternatively, the vector may be one which, when introduced mto a host cell, is integrated mto the host cell genome and replicated together with the chromosome (s) into which it has been integrated.
In the vector, the DNA sequence should be operably connected to a suitable promoter sequence. The promoter may be any DNA sequence which shows transcriptional activity m the host cell of choice and may be derived from genes encoding pro- terns either homologous or heterologous to the host cell . Examples of suitable promoters for directing the transcription of the DNA sequence encoding an a-amylase of the invention, especially a bacterial host, are the promoter of the lac operon of E . coli , the Streptomyces coeli color agarase gene dagA promoters, the promoters of the Bacillus licheniformi s a- amylase gene { amyL) , the promoters of the Bacillus stearothermophilus maltogenic amylase gene { amyM) , the promoters of the Bacillus Amyloliquefaciens a-a ylase ( amyQ) , the promoters of the Bacillus subtili s xylA and xylB genes etc. For transcription m a fungal host, examples of useful promoters are those derived from the gene encoding A . oryzae TAKA amylase, Rhizomucor wiehei aspartic protemase, A . niger neutral a-amylase, A . niger acid stable a-amylase, A . niger glu- coamylase, Rhizomucor miehei lipase, A . oryzae alkaline protease, A . oryzae triose phosphate isomerase or A . nidulans acetamidase .
The expression vector of the invention may also comprise a suitable transcription terminator and, m eukaryotes, poly- adenylation sequences operably connected to the DNA sequence encoding the a-amylase of the invention. Termination and poly- adenylation sequences may suitably be derived from the same sources as the promoter.
The vector may further comprise a DNA sequence enabling the vector to replicate m the host cell m question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUBHO, pE194, pAMBl and pIJ702. 9
The vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect m the host cell, such as the dal genes from B . subtili s or B . li chemfor- mis , or one which confers antibiotic resistance such as ampi- cillm, kanamycm, chloramphenicol or tetracyclm resistance. Furthermore, the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and sC, a marker giving rise to hygromyc resistance, or the selection may be accomplished by co-transformation, e.g. as described m WO 91/17243. While mtracellular expression may be advantageous m some respects, e.g. when using certain bacteria as host cells, it is generally preferred that the expression is extracellular.
Procedures suitable for constructing vectors of the invention encoding an a-amylase , and containing the promoter, terminator and other elements, respectively, are well known to persons skilled m the art [cf . , for instance, Sambrook et al . (1989) ] .
Host cells
The cell of the invention, either comprising a DNA con- struct or an expression vector of the invention as defined above, is advantageously used as a host cell m the recombinant production of the a-amylase of the invention. The cell may be transformed with the DNA construct of the invention encoding the amylase, conveniently by integrating the DNA construct (m one or more copies) m the host chromosome. This integration is generally considered to be an advantage as the DNA sequence is more likely to be stably maintained the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g. by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above m connection with the different types of host cells.
The cell of the invention may be a cell of a higher organism such as a mammal or an insect, but is preferably a microbial cell, e.g. a bacterial or a fungal (including yeast) cell. 10
Examples of bacterial host cells which, on cultivation, are capable of producing the enzyme of the invention are gram-positive bacteria such as strains of Bacillus, such as strains of B . subtilis , B . li chenifor i s , B . lentus, B . clausn , B . brevi s, B . s tearothermophilus, B . alkalophilus , B . amyloliquefaciens, B . coagulans , B . circulans , B . lautus , B . mega terium or B . thuringi ensi s, or strains of Streptomyces, such as S . lividans or S . murmus, or gram-negative bacteria such as Escherichia coll . The transformation of the bacteria may be effected by protoplast transformation, electroporation, conjugation, or by using competent cells m a manner known per se (cf. Sambrook et al . , supra) .
The yeast organism may favourably be selected from a species of Saccharomyces or Schizosaccharomyces , e.g. Saccharomyces cerevi siae . The filamentous fungus may advantageously belong to a species of Aspergillus, e.g. Aspergillus oryzae or Aspergillus niger. Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall m a manner known per se . A suitable procedure for transformation of Aspergillus host cells is described m EP 238 023.
Industrial Applications
Owing to their activity at alkaline pH values, the a- amylases of the invention are well suited for use m a variety of industrial processes, m particular the enzyme finds potential applications as a component m detergents, e.g. laundry and hard surface cleaning detergent compositions, but it may also be useful the production of sweeteners and ethanol from starch. Thus, it may be used m conventional starch- converting processes, such as liquefaction and saccharification processes described US Patent No. 3,912,590 and EP patent publications Nos . 252,730 and 63,909.
The alkaline a-amylase of the invention may also be used in the production of lignocellulosic materials, such as pulp, paper and cardboard, from starch reinforced waste paper and cardboard, especially where repulp g occurs at pH above 7 and 11
where amylases can facilitate the disintegration of the waste material through degradation of the reinforcing starch. The a- amylase of the mvention is especially useful m a process for producing a paper akmg pulp from starch-coated printed paper. The process may be performed as described m WO 95/14807, comprising the following steps: a) disintegrating the paper to produce a pulp, b) treating with a starch-degrading enzyme before, during or after step a) , and c) separating ink particles from the pulp after steps a) and b) .
The a-amylases of the invention may also be very useful m modifying starch where enzymatically modified starch is used papermakmg together with alkaline fillers such as calcium carbonate, kaolin and clays. With the alkaline a-amylases of the invention it becomes possible to modify the starch the presence of the filler thus allowing for a simpler integrated process .
The a-amylase of the invention may also be very useful m textile desizmg. In the textile processing industry, a- amylases are traditionally used as auxiliaries m the desizmg process to facilitate the removal of starch-contammg size which has served as a protective coatmg on weft yarns during weaving. Complete removal of the size coatmg after weaving is important to ensure optimum results m the subsequent processes, m which the fabric is scoured, bleached and dyed. Enzymatic starch break-down is preferred because it does not involve any harmful effect on the fiber material . In order to reduce processing cost and increase mill throughput, the desizmg processing is sometimes combined with the scouring and bleaching steps. In such cases, non-enzymatic auxiliaries such as alkali or oxidation agents are typically used to break down the starch, because traditional a-amylases are not very compatible with high pH levels and bleaching agents. The non- enzymatic breakdown of the starch size does lead to some fiber damage because of the rather aggressive chemicals used. Accordingly, it would be desirable to use the a-amylases of the 12
invention as they have an improved performance m alkaline solutions. The a-amylases may be used alone or m combination with a cellulase when desizmg cellulose-containing fabric or textile . The a-amylases of the invention may also be very useful m a beer-making process; the a-amylases will typically be added during the mashing process.
Detergent Compositions
According to the invention, the a-amylase may typically be a component of a detergent composition, e.g., a laundry detergent composition. As such, it may be included m the detergent composition m the form of a non-dustmg granulate, a stabilized liquid, or a protected enzyme. Non-dustmg granulates may be produced, e.g., as disclosed m US 4,106,991 and 4,661,452 (both to Novo Industri A/S) and may optionally be coated by methods known m the art. Examples of waxy coatmg materials are poly (ethylene oxide) products (polyethyleneglycol , PEG) with mean molecular weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols m which the alcohol contains from 12 to 20 carbon atoms and m which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and tπglycerides of fatty acids. Examples of film-forming coatmg materials suitable for application by fluid bed techniques are given m patent GB 1483591. Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol , a sugar or sugar alcohol, lactic acid or boric acid according to established methods. Other enzyme stabilizers are well known m the art. Protected enzymes may be prepared according to the method disclosed m EP 238,216.
The properties of the alpha-amylase of the invention make it particularly suitable for use m alkaline detergents, e.g. at pH 9.5-10.5, and for washing at low temperatures, e.g. 20- 40°C. The detergent composition of the invention may be any convenient form, e.g. as powder, granules, paste or liquid. A 13
liquid detergent may be aqueous, typically containing up to 70% water and 0-30% organic solvent, or non-aqueous.
The detergent composition comprises one or more surfactants, each of which may be anionic, nonionic, cationic, or amphoteric (zwitterionic) . The detergent will usually contain 0-50% of anionic surfactant such as linear alkylbenzene- sulfonate (LAS) , alpha-olefmsulfonate (AOS) , alkyl sulfate (fatty alcohol sulfate) (AS), alcohol ethoxysulfate (AEOS or AES) , secondary alkanesulfonates (SAS) , alpha-sulfo fatty acid methyl esters, alkyl- or alkenylsuccmic acid, or soap. It may also contain 0-40% of nonionic surfactant such as alcohol ethoxylate (AEO or AE) , alcohol propoxylate, carboxylated alcohol ethoxylates, nonylphenol ethoxylate, alkylpolygly- coside, alkyldimethylamme oxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, or polyhydroxy alkyl fatty acid amide (e.g. as described m WO 92/06154) .
The detergent composition may additionally comprise one or more other enzymes, such as pullulanase, esterase, lipase, cutmase, protease, cellulase, peroxidase, or oxidase, e.g., laccase.
Normally the detergent contains 1-65% of a detergent builder or complexmg agent such as zeolite, diphosphate, tri- phosphate, phosphonate, citrate, mtrilotriacetic acid (NTA) , ethylenediammetetraacetic acid (EDTA) , diethylenetπ- ammepentaacetic acid (DTMPA) , alkyl- or alkenylsuccmic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst) .
The detergent builders may be subdivided into phosphorus- containing and non-phosphorous-containing types. Examples of phosphorus-containing inorganic alkaline detergent builders include the water-soluble salts, especially alkali metal pyrophosphates, orthophosphates , polyphosphates and phospho- nates . Examples of non-phosphorus-containing inorganic builders include water-soluble alkali metal carbonates, borates and silicates as well as layered disilicates and the various types of water-insoluble crystalline or amorphous alummo silicates of which zeolites is the best known representative. 14
Examples of suitable organic builders include alkali metal, ammonium or substituted ammonium salts of succmates, malonates, fatty acid malonates, fatty acid sulphonates, carboxymethoxy succmates, polyacetates , carboxylates , polycar- boxylates, ammopolycarboxylates and polyacetyl carboxylates. The detergent may also be unbuilt, i.e. essentially free of detergent builder.
The detergent may comprise one or more polymers. Examples are carboxymethylcellulose (CMC), poly (vmylpyrrolidone) (PVP) , polyethyleneglycol (PEG), poly (vinyl alcohol) (PVA) , poly- carboxylates such as polyacrylates, polymaleates , maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
The detergent composition may contain bleaching agents of the chlorme/bromme-type or the oxygen-type. The bleaching agents may be coated or encapsulated.
Examples of inorganic chlorme/bromme-type bleaches are lithium, sodium or calcium hypochloπte or hypobromite as well as chlorinated tπsodium phosphate. Examples of organic chlorme/bromme-type bleaches are heterocyclic N-bromo and N- chloro lmides such as trichloroisocyanuπc , tπbromoiso- cyanuric, dibromoisocyanuric and dichloroisocyanuric acids, and salts thereof with water solubiliz g cations such as potassium and sodium. Hydantom compounds are also suitable. The bleaching system may also comprise peroxyacids of, e.g., the amide, lmide, or sulfone type.
The oxygen-type bleach may be an inorganic persalt, preferably with a bleach activator, or a peroxy acid compound. Examples of inorganic persalts are alkali metal perborates, both tetrahydrates and monohydrates, alkali metal percarbonates , persilicates and perphosphates . The activator may be tetraacetylethylenediamme (TAED) or nonanoyloxybenzene- sulfonate (NOBS) .
The enzymes of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g. a polyol such as propylene glycol or glycerol , a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative 15
such as, e.g., an aromatic borate ester, and the composition may be formulated as described in, e.g., WO 92/19709 and WO 92/19708. The enzymes of the invention may also be stabilized by adding reversible enzyme inhibitors, e.g., of the protein type as described in EP 0 544 777 Bl .
The detergent may also contain other conventional detergent ingredients such as, e.g., fabric conditioners including clays, deflocculant material, foam boosters, foam depressors, suds suppressors, anti -corrosion agents, soil -suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides , optical brighteners, or perfume.
The pH (measured in aqueous solution at use concentration) will usually be neutral or alkaline, e.g. in the range of 7-11. More specifically, the alpha-amylase of the invention may be incorporated in any of the detergent formulations described in WO 96/23873.
The a-amylases of the invention may be incorporated in concentrations conventionally employed in detergents. It is at present contemplated that, in the detergent composition of the invention, the a-amylase may be added in an amount corresponding to 0.00001-1 mg (calculated as pure enzyme protein) of a- amylase per liter of wash liquor.
The present invention is further illustrated in the following examples which are not intended to be in any way limiting to the scope of the invention as claimed.
EXAMPLES
Host organism:
Escherichia coli SJ2 is described in Diderichsen, B., Wedsted, U. , Hedegaard, L., Jensen, B.R., Sjøholm, C. (1990) Journal of Bacteriology, Vol.172, No. 8, p. 4315-4321.
Plasmids :
The gene bank vector was pSJ1678 which is further disclosed in W094/19454 which is hereby incorporated by reference. 16
The gene bank vector pSJ1678 is further disclosed m WO 94/19454 which is hereby incorporated by reference.
Model detergent :
A/P (Asia/Pacific) Model Detergent has the following composition: 20% STPP (sodium tripolyphosphate) , 25% Na2S04,
15% Na2C03, 20% LAS (linear alkylbenzene sulfonate, Nansa 80S) ,
5% C12-C15 alcohol ethoxylate (Dobanol 25-7), 5% Na2Si205, 0.3%
NaCl .
Example 1 Cloning of alpha-amylase into E. coli
DNA was isolated from Bacillus sp . NCIMB 40916 by the method of Pitcher, D. G., Saunders,N. A., and Owen, R. J.
(1989) Lett. Appi . Microbiol . 8, 151-156. Chromosomal DNA was partially digested with the restriction enzyme Sau3AI . The fragments were cloned into the BamHI site of the cloning vector pSJ1678, as shown in Figure 4 and transformed into Escherichia coli SJ2 , thereby creating a gene library of Bacillus sp . NCIMB 40916.
This gene library was screened for alpha amylase activity and the strain showing alpha amylase activity was termed JA388. This Escheri chia coli strain JA388 which was deposited and given the accession number DSM 12662, and which harbours the plasmid termed pJA388 encoding the alpha amylase was used for DNA sequencing.
Example 2
Sequencing of DNA and alpha-amylase
The Alpha amylase gene cloned in plasmid pJA388 was characterized by DNA sequencing by primer walking, using the
Taq deoxytermmal cycle sequencing kit (Perkm Elmer, USA) , fluorescent labeled terminators and appropriate oligonucleotides as primers.
Analysis of the sequence data was performed according to
Devereux et al . (1984) Nucleic Acids Res. 12, 387-395. The sequence corresponds to the DNA sequence shown in SEQ ID NO: 1. The predicted protein sequence of the alpha amylase including 17
the signal peptide and the mature alpha amylase are presented m SEQ ID NO: 2. The deduced N-termmal sequence was verified by sequencing 34 ammo acids at the N-termmal of the protein.
Example 3 Production of alpha-amylase
E . coli JA388 harboring plasmid pJA388 was cultivated over night m LB-broth containing chloramphenicol 10 μg/ml , 37 °C, 250 rpm. Cells were harvested from 2.7 1 culture broth by centrifugation at 6000 rpm for 15 minutes. The mtracellular located amylase was released from the cells by using the following osmotic shock procedure:
1) Cells were resuspended and washed m 500 ml 10 mM Tris- HC1 , pH 7.0 (EKV-buffer) followed by centrifugation.
2) Cells were resuspended m 75 ml 20% sucrose, 30 mM Tris-HCl pH 8, 1 mM EDTA and added Lysozyme to a concentration of 5 mg/ml .
3) The solution was incubated 15 mm on ice followed by centrifugation. The majority of the amylase was now contained m the supernatant . The supernatant was dialyzed overnight agamst 10 1 m EKV-buffer with one buffer change to decrease the high concentration of sucrose. The solution was filtered through a 0.45 μm membrane vacuum filter.
The enzyme solution was applied on a Pharmacia Q Sepharose column FF previously equilibrated m EKV-buffer, pH 7, and the column was washed with EKV-buffer. Bound proteins were eluted with a linear NaCl gradient from 0-500 mM over 10 column volumes. Amylase containing fractions were pooled and dialyzed aga st EKV-buffer over night. The solution was then applied on a Q Sepharose column FF previously equilibrated m EKV-buffer, pH 8, the column was washed with EKV-buffer, and the amylase was eluted with a linear NaCl gradient from 0-500 mM over 10 column volumes. Amylase containing fractions were pooled. A Phenyl Superose column previously equilibrated m EKV- buffer, pH 8 containing 1 M ammonium sulfate was loaded with 18
the enzyme solution added ammonium sulfate to a concentration of 1 M. Unbound material was washed out with the ammonium sulfate buffer and the column was eluted with a linear NaCl gradient from 1-0 M ammonium sulfate over 20 column volumes. Amylase containing fractions were pooled.
The purified amylase was analyzed by SDS-PAGE and only one band was obtained after staining with Coomasie Blue.
Example 4 Washing test Washing performance was evaluated by washing soiled test swatches for 15 minutes at 25°C m a detergent solution with the alpha-amylase of the invention.
The detergent used was the A/P Model Detergent described above at 3 g/1 having pH 10.5, or a commercial detergent from Malaysia (FAB Total from Colgate) at 3 g/1 having a pH of approx. 9.7. The purified amylase of Example 3 was added to the detergent solution at the concentration indicated below. The test swatches were soiled with orange rice starch (CS-28 swatches available from CFT, Center for Test Material, Holland) .
After washing, the swatches were evaluated by measuring the remission at 460 nm. The results are expressed as ΔR = remission of the swatch washed with the alpha-amylase minus the remission of a swatch washed at the same conditions without the alpha-amylase.
Alpha-amylase ΔR ΔR concentration Model detergent Malaysian detergent (mg enzyme protein
/ 1)
0 (reference) = 0 = 0
0.1 0.9 1
0.2 1.9 1.3
0.5 3 2.4
1.5 4.1 4.3 19
The results are shown m Figures 5 and 6. The results demonstrate that the alpha-amylase of the invention is effective m both detergents at highly alkaline pH.

Claims

20CLAIMS
1. An alpha-amylase which is: a) a polypeptide produced by Bacillus sp . NCIMB 40916, or b) a polypeptide having an amino acid sequence as shown in positions 32-532 of SEQ ID NO: 2, or c) a polypeptide encoded by the alpha-amylase encoding part of the DNA sequence cloned into a plasmid present in Escheri chia coli DSM 12662, or d) an analogue of the polypeptide defined in (a) or (b) which: i) is at least 60 % homologous with said polypeptide, or ii) is derived from said polypeptide by substitution, deletion and/or insertion of one or more amino acids.
2. An alpha-amylase which has an activity at pH 10.5 which is at least two times higher than the activity at pH 7.3 when measured at 37┬░C.
3. An alpha-amylase which has an activity at pH 9.5 which is at least 4 times higher than the activity at pH 7.3 when measured at 37┬░C.
4. An alpha-amylase which has an optimum pH of about 9.5 when measured at 37┬░C.
5. The alpha-amylase of any preceding claim which is from a strain of Bacillus , preferably Bacillus sp . NCIMB 40916.
6. The alpha-amylase of any preceding claim which retains more than 90 % of its activity after 20 minutes incubation at 25┬░C in a solution of 3 g/1 of a test detergent containing 20% STPP, 25% Na2S04, 15% Na2C03, 20% LAS, 5% C12-C15 alcohol ethoxylate, 5% Na2Si205, 0.3% NaCl at pH 10.5 and 6 degrees 21
German hardness, and retains less than 90 % of its activity after 20 minutes incubation at 30┬░C m the same solution.
7. The alpha-amylase of any preceding claim which has a molecular weight of about 55 kDa as determined by SDS-PAGE.
8. The alpha-amylase of any preceding claim which has an isoelectric point of about 5 as determined by isoelectric focusing .
9. The alpha-amylase of any preceding claim m the form of a detergent additive which is a non-dustmg granulate or a stabilized liquid.
10. An isolated DNA sequence which encodes the alpha-amylase of any of preceding claim.
11. An isolated DNA sequence which encodes an alpha-amylase and comprises: a) the DNA sequence shown in positions 94-1596 of SEQ ID NO: 1, or b) an analogue of the DNA sequence defined m a) which l) is at least 60 % homologous with said DNA sequence, or ii) hybridizes with said DNA sequence at least 55┬░C.
12. The DNA sequence according to claim 10 or 11, which is from a bacterium, preferably from Bacillus , most preferably from the strain NCIMB 40916.
13. A recombinant expression vector comprising the DNA sequence according to any of claims 10-12.
14. A cell transformed with the DNA sequence according to any of claims 10-12 or the recombinant expression vector according to claim 13. 22
15. The cell according to claim 14, which is a prokaryotic cell, in particular a bacterial cell or an endogenous cell from which said DNA sequence originates.
16. The cell according to claim 15, wherein the cell belongs 5 to Bacillus or Escherichia , preferably E. coli .
17. A method of producing an alpha-amylase, comprising cultivating a cell according to any of claims 14-16 under conditions permitting the production of the alpha-amylase, and recovering the alpha-amylase from the culture.
10 18. A method for producing the alpha-amylase of any of the preceding claims, comprising cultivating an amylase-producing strain of Bacillus in a suitable nutrient medium, and recovering the alpha-amylase from the culture medium.
19. A detergent composition comprising the alpha-amylase of is any of claims 1-9 and a surfactant.
20. The detergent composition of the preceding claim which has a pH of 8.5-11 in aqueous solution, preferably pH 9-10.5
21. The detergent composition of claim 19 or 20 which is a laundry detergent.
EP99903592A 1998-02-18 1999-02-15 Alkaline bacillus amylase Withdrawn EP1054957A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK22898 1998-02-18
DK22898 1998-02-18
PCT/DK1999/000066 WO1999042567A1 (en) 1998-02-18 1999-02-15 Alkaline bacillus amylase

Publications (1)

Publication Number Publication Date
EP1054957A1 true EP1054957A1 (en) 2000-11-29

Family

ID=8091176

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99903592A Withdrawn EP1054957A1 (en) 1998-02-18 1999-02-15 Alkaline bacillus amylase

Country Status (6)

Country Link
EP (1) EP1054957A1 (en)
JP (1) JP2002504323A (en)
KR (1) KR20010040517A (en)
AU (1) AU2411699A (en)
CA (1) CA2320759A1 (en)
WO (1) WO1999042567A1 (en)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6686200A (en) * 1999-08-20 2001-03-19 Novozymes A/S Alkaline bacillus amylase
EP3000881A3 (en) 2001-05-15 2016-07-20 Novozymes A/S Alpha-amylase variant with altered properties
CN100497593C (en) * 2005-10-19 2009-06-10 新疆农业科学院微生物应用研究所 Low-temperature amylase strain, low-temperature amylase, and production therefor
MX353621B (en) 2011-06-30 2018-01-22 Novozymes As Alpha-amylase variants.
WO2014194034A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194054A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
US20160108387A1 (en) 2013-05-29 2016-04-21 Danisco Us Inc. Novel metalloproteases
EP3004314B1 (en) 2013-05-29 2018-06-20 Danisco US Inc. Novel metalloproteases
US10533165B2 (en) 2013-12-13 2020-01-14 Danisco Us Inc Serine proteases of the bacillus gibsonii-clade
DK3080262T3 (en) 2013-12-13 2019-05-06 Danisco Us Inc SERIN PROTEAS OF BACILLUS SPECIES
AU2014366222B2 (en) 2013-12-16 2018-07-19 Nutrition & Biosciences USA 4, Inc. Use of poly alpha-1,3-glucan ethers as viscosity modifiers
US9957334B2 (en) 2013-12-18 2018-05-01 E I Du Pont De Nemours And Company Cationic poly alpha-1,3-glucan ethers
CN105992796A (en) 2014-02-14 2016-10-05 纳幕尔杜邦公司 Poly-alpha-1,3-1,6-glucans for viscosity modification
CA2937830A1 (en) 2014-03-11 2015-09-17 E. I. Du Pont De Nemours And Company Oxidized poly alpha-1,3-glucan as detergent builder
EP3119884B1 (en) 2014-03-21 2019-07-10 Danisco US Inc. Serine proteases of bacillus species
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
EP3158043B1 (en) 2014-06-19 2021-03-10 Nutrition & Biosciences USA 4, Inc. Compositions containing one or more poly alpha-1,3-glucan ether compounds
US20170233710A1 (en) 2014-10-17 2017-08-17 Danisco Us Inc. Serine proteases of bacillus species
US20170335306A1 (en) 2014-10-27 2017-11-23 Danisco Us Inc. Serine proteases
WO2016069544A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069552A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
US20180010074A1 (en) 2014-10-27 2018-01-11 Danisco Us Inc. Serine proteases of bacillus species
EP3212782B1 (en) 2014-10-27 2019-04-17 Danisco US Inc. Serine proteases
JP2018512109A (en) 2014-12-23 2018-05-17 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company Cellulose produced by enzymes
EP4219704A3 (en) 2015-05-13 2023-08-23 Danisco US Inc Aprl-clade protease variants and uses thereof
WO2016201044A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Osmotic burst encapsulates
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
EP3310911B1 (en) 2015-06-17 2023-03-15 Danisco US Inc. Bacillus gibsonii-clade serine proteases
EP4141113A1 (en) 2015-11-05 2023-03-01 Danisco US Inc Paenibacillus sp. mannanases
CN108603183B (en) 2015-11-05 2023-11-03 丹尼斯科美国公司 Paenibacillus species and bacillus species mannanases
EP3374400B1 (en) 2015-11-13 2022-04-13 Nutrition & Biosciences USA 4, Inc. Glucan fiber compositions for use in laundry care and fabric care
EP3374488B1 (en) 2015-11-13 2020-10-14 DuPont Industrial Biosciences USA, LLC Glucan fiber compositions for use in laundry care and fabric care
US10822574B2 (en) 2015-11-13 2020-11-03 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
WO2017100720A1 (en) 2015-12-09 2017-06-15 Danisco Us Inc. Alpha-amylase combinatorial variants
US20180362946A1 (en) 2015-12-18 2018-12-20 Danisco Us Inc. Polypeptides with endoglucanase activity and uses thereof
WO2017192692A1 (en) 2016-05-03 2017-11-09 Danisco Us Inc Protease variants and uses thereof
US20190136218A1 (en) 2016-05-05 2019-05-09 Danisco Us Inc Protease variants and uses thereof
CA3026064A1 (en) 2016-05-31 2017-12-07 Danisco Us Inc. Protease variants and uses thereof
JP7152319B2 (en) 2016-06-17 2022-10-12 ダニスコ・ユーエス・インク Protease variants and uses thereof
WO2018085524A2 (en) 2016-11-07 2018-05-11 Danisco Us Inc Laundry detergent composition
WO2018118917A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Protease variants and uses thereof
WO2018118950A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
US11453871B2 (en) 2017-03-15 2022-09-27 Danisco Us Inc. Trypsin-like serine proteases and uses thereof
WO2018184004A1 (en) 2017-03-31 2018-10-04 Danisco Us Inc Alpha-amylase combinatorial variants
WO2018183662A1 (en) 2017-03-31 2018-10-04 Danisco Us Inc Delayed release enzyme formulations for bleach-containing detergents
US10400235B2 (en) 2017-05-26 2019-09-03 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
US20200131456A1 (en) 2017-06-30 2020-04-30 Danisco Us Inc Low-agglomeration, enzyme-containing particles
RU2020111041A (en) 2017-08-18 2021-09-20 ДАНИСКО ЮЭс ИНК ALPHA-AMYLASE OPTIONS
WO2019108599A1 (en) 2017-11-29 2019-06-06 Danisco Us Inc Subtilisin variants having improved stability
BR112020012584A2 (en) 2017-12-21 2020-11-24 Danisco Us Inc. hot melt granules containing enzyme which comprise a thermotolerant desiccant
EP3749107A1 (en) 2018-02-08 2020-12-16 Danisco US Inc. Thermally-resistant wax matrix particles for enzyme encapsulation
WO2019245704A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
EP3799601A1 (en) 2018-06-19 2021-04-07 Danisco US Inc. Subtilisin variants
WO2020028443A1 (en) 2018-07-31 2020-02-06 Danisco Us Inc Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid
US20210189295A1 (en) 2018-08-30 2021-06-24 Danisco Us Inc Enzyme-containing granules
WO2020068486A1 (en) 2018-09-27 2020-04-02 Danisco Us Inc Compositions for medical instrument cleaning
EP3864148A2 (en) 2018-10-12 2021-08-18 Danisco US Inc. Alpha-amylases with mutations that improve stability in the presence of chelants
EP3887515A1 (en) 2018-11-28 2021-10-06 Danisco US Inc. Subtilisin variants having improved stability
EP3976776A1 (en) 2019-05-24 2022-04-06 Danisco US Inc. Subtilisin variants and methods of use
CN114174486A (en) 2019-06-06 2022-03-11 丹尼斯科美国公司 Method and composition for cleaning
EP4048683A2 (en) 2019-10-24 2022-08-31 Danisco US Inc Variant maltopentaose/maltohexaose-forming alpha-amylases
EP4204553A1 (en) 2020-08-27 2023-07-05 Danisco US Inc. Enzymes and enzyme compositions for cleaning
US20240117275A1 (en) 2021-01-29 2024-04-11 Danisco Us Inc. Compositions for cleaning and methods related thereto
CN117083370A (en) 2021-03-26 2023-11-17 诺维信公司 Detergent compositions with reduced polymer content
WO2023278297A1 (en) 2021-06-30 2023-01-05 Danisco Us Inc Variant lipases and uses thereof
WO2023034486A2 (en) 2021-09-03 2023-03-09 Danisco Us Inc. Laundry compositions for cleaning
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114939A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114936A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114988A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Variant maltopentaose/maltohexaose-forming alpha-amylases
WO2023168234A1 (en) 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
WO2023250301A1 (en) 2022-06-21 2023-12-28 Danisco Us Inc. Methods and compositions for cleaning comprising a polypeptide having thermolysin activity
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9903559A3 (en) * 1996-08-01 2000-08-28 Procter & Gamble Detergent compositions comprising improved amylase for dingy fabric clean-up

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9942567A1 *

Also Published As

Publication number Publication date
JP2002504323A (en) 2002-02-12
WO1999042567A1 (en) 1999-08-26
KR20010040517A (en) 2001-05-15
AU2411699A (en) 1999-09-06
CA2320759A1 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
EP1212409B1 (en) Alkaline bacillus amylase
WO1999042567A1 (en) Alkaline bacillus amylase
US7794997B2 (en) Alkaline Bacillus amylase
US5856164A (en) Alkaline bacillus amylase
US5989169A (en) α-amylase mutants
JP4116074B2 (en) Amylase variant
KR100787392B1 (en) Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
JP5492879B2 (en) Geobacillus stearothermophilus alpha amylase (AmyS) variant with improved properties
FI119996B (en) amylase variants
MXPA96004313A (en) Amilasa de bacillus alcal
JP2011504100A (en) Variants of Bacillus licheniformis alpha amylase with increased thermal stability and / or decreased calcium dependence
KR20100085964A (en) Alpha-amylase variants with altered properties
US5830837A (en) Amylase variants
US7078213B1 (en) Alkaline Bacillus amylase
WO2013096305A1 (en) Variant alpha-amylases and methods of use, thereof
EP2199386A1 (en) Amylase variants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000918

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVOZYMES A/S

17Q First examination report despatched

Effective date: 20031015

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060524